A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.
Status:
Recruiting
Trial end date:
2023-05-10
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and efficacy of two doses of
CNTX-6970 for the treatment of pain related to OA of the knee compared to placebo. CNTX-6970
is being developed as a new treatment for chronic pain, including painful osteoarthritis of
the knee.